Matthew Hylton, NP
Primary Care · New Brunswick, NJNPI 1538834858
Payments from drug & device makers
Across 19 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$95
- Bausch Health US, LLC$74
- Boston Scientific$66
- E.r. Squibb & Sons, L.L.C.$38
- AbbVie$19
- Edwards Lifesciences$17
- plus $28 from 2 others
What the payments were for
- Food & beverage$336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 5 | $95 |
| Bausch Health US, LLC | 5 | $74 |
| Boston Scientific | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| AbbVie | 1 | $19 |
| Edwards Lifesciences | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
How this compares
$336 in reported general payments places this provider in the 45th percentile of 330 primary care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 51 | $2,210 |
| Quetiapine Fumarate | 70 | $1,172 |
| Divalproex Sodium | 23 | $1,000 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $788 |
| Olanzapine | 35 | $666 |
| Duloxetine Hcl | 15 | $592 |
| Hydroxyzine Hcl | 38 | $496 |
| Ziprasidone Hcl | 14 | $484 |
| Haloperidol | 19 | $482 |
| Benztropine Mesylate | 44 | $414 |
| Mirtazapine | 26 | $376 |
| Fluoxetine Hcl | 18 | $300 |
| Doxepin Hcl | 12 | $295 |
| Sertraline Hcl | 59 | $293 |
| Bupropion XlBupropion Hcl | 19 | $289 |
Paid to pharmacies, not to this prescriber.
Other primary care in New Brunswick
- Agnes SalamonNew Brunswick$5K
- Elizabeth RamirezNew Brunswick$3K
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.